Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699

Condition:   Cushing's Syndrome Intervention:   Drug: osilodrostat Sponsor:   Novartis Pharmaceuticals Not yet recruiting

Source: ClinicalTrials.gov - July 30, 2018 Category: Research Source Type: clinical trials